Chronic COUGH Management in Interstitial Lung DisEase

Launched by AVEIRO UNIVERSITY · Jan 14, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on improving the lives of people with Interstitial Lung Disease (ILD) who experience chronic cough, which is a cough lasting more than eight weeks. Chronic cough is a common and challenging symptom for those with ILD, affecting about 8 out of 10 patients. It can lead to problems such as difficulty sleeping, feelings of depression, and social isolation. The goal of this study is to see how a non-drug treatment can help reduce cough frequency and intensity, improve overall quality of life, and better manage other related symptoms like breathlessness and fatigue.

To be eligible for the trial, participants need to be adults over 18 years old, have a confirmed diagnosis of ILD, and have a chronic cough. They should also have access to a way to participate in virtual meetings or phone calls. The trial is not yet recruiting participants, but once it begins, those who join can expect to learn more about managing their cough and its effects on their daily life. It's important to note that individuals with certain conditions, like significant sputum production or recent respiratory infections, will not be able to participate.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • i) Adults (\>18 years old) ii) Clinical diagnosis of ILD iii) Presenting chronic cough (\> 8 weeks of duration) iv) People with access to a virtual meeting platform/telephone.
• Exclusion Criteria:
• • i) Self-reports of moderate or large sputum production (\> 2 tablespoons); ii) Actual or suspected exacerbation of the respiratory condition in the last month; iii) Upper respiratory tract infection (e.g. cold); iv) Use of angiotensin-converting enzyme inhibitor medication; v) Changes in prescribed medication in the last month; vi) Signs of cognitive impairment or significant cardiovascular, neurological and/or musculoskeletal disease that may limit participation in the program; vii) Inability to read or speak Portuguese; viii) Inability to provide informed consent.